bites blinatumomab Search Results


bite- blinatumomab  (Glaxo Smith)
90
Glaxo Smith bite- blinatumomab
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Bite Blinatumomab, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bite- blinatumomab/product/Glaxo Smith
Average 90 stars, based on 1 article reviews
bite- blinatumomab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bite blinatumomab  (Wolters Kluwer Health)
90
Wolters Kluwer Health bite blinatumomab
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Bite Blinatumomab, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bite blinatumomab/product/Wolters Kluwer Health
Average 90 stars, based on 1 article reviews
bite blinatumomab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bite (blinatumomab)  (Kimble Inc)
90
Kimble Inc bite (blinatumomab)
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Bite (Blinatumomab), supplied by Kimble Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bite (blinatumomab)/product/Kimble Inc
Average 90 stars, based on 1 article reviews
bite (blinatumomab) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bi-specific t cell adaptor (bite) blinatumomab  (Amgen)
90
Amgen bi-specific t cell adaptor (bite) blinatumomab
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Bi Specific T Cell Adaptor (Bite) Blinatumomab, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bi-specific t cell adaptor (bite) blinatumomab/product/Amgen
Average 90 stars, based on 1 article reviews
bi-specific t cell adaptor (bite) blinatumomab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
blinatumomab bite  (MedImmune llc)
90
MedImmune llc blinatumomab bite
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Blinatumomab Bite, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blinatumomab bite/product/MedImmune llc
Average 90 stars, based on 1 article reviews
blinatumomab bite - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bite(r) immunotherapy blinatumomab  (Amgen)
90
Amgen bite(r) immunotherapy blinatumomab
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Bite(R) Immunotherapy Blinatumomab, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bite(r) immunotherapy blinatumomab/product/Amgen
Average 90 stars, based on 1 article reviews
bite(r) immunotherapy blinatumomab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
bite®-antikörper blinatumomab  (Serono)
90
Serono bite®-antikörper blinatumomab
Effects of FDA-approved and investigational agents on the myeloma immune microenvironment
Bite® Antikörper Blinatumomab, supplied by Serono, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bite®-antikörper blinatumomab/product/Serono
Average 90 stars, based on 1 article reviews
bite®-antikörper blinatumomab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Effects of FDA-approved and investigational agents on the myeloma immune microenvironment

Journal: Cancer Drug Resistance

Article Title: Therapeutics to harness the immune microenvironment in multiple myeloma

doi: 10.20517/cdr.2022.23

Figure Lengend Snippet: Effects of FDA-approved and investigational agents on the myeloma immune microenvironment

Article Snippet: The prototypical BiTE- blinatumumab (Glaxo-Smith Kline) targets CD3 and CD19 to facilitate T cell-mediated killing of relapsed acute lymphocytic leukemia (ALL) cells [ ] [ , ] .

Techniques: Bioprocessing, Activation Assay, In Vitro, Expressing, Activity Assay